Memantine and blood albumin decreased Patient Reports February 12, 2012

Memantine Side Effects Report #5642287-3
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on July 24, 2007. Male patient, 90 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood albumin decreased, chest pain , cholecystitis, cholelithiasis, depressed mood, disease recurrence, heart rate increased, pyrexia. Memantine dosage: unknown. During the same period patient was treated with DONEPEZIL, AMBROXOL HYDROCHLORIDE, SIENNA LEAF, RANITIDINE HYDROCHLORIDE, TEPRENONE, URSODESOXYCHOLIC ACID. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5632519-X
Memantine side effect was reported by a Physician from UNITED STATES on Feb 07, 2008. Female patient, 88 years of age, weighting 114.0 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: asthenia, blood albumin decreased, blood amylase increased, blood pressure systolic increased, brain natriuretic peptide increased, cardiac failure congestive, carotid artery disease , coronary artery insufficiency, dementia . Memantine dosage: 28 MG QD PO. During the same period patient was treated with DONEPEZIL, FOLIC ACID, MIRTAZAPINE, RISEDRONATE, DOCUSATE, RANITIDINE, TRIMETHOPRIM, DARVOCET. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #4871960-X
Memantine side effect was reported by a Health Professional from UNITED STATES on Dec 20, 2005. Female patient, 87 years of age, weighting 116.0 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: anion gap decreased, back pain , blood albumin decreased, blood chloride increased, blood glucose increased, blood potassium increased, blood pressure diastolic increased, cold sweat, confusional state. Memantine dosage: unknown. During the same period patient was treated with NORVASC, OSTEOBIFLEX, PRINIVIL, ASPIRIN, LIDODERM, ARICEPT. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #4899938-0
Memantine side effect was reported by a Physician from UNITED STATES on Jan 24, 2006. Female patient, 87 years of age, weighting 116.0 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: anion gap decreased, back pain , blood albumin decreased, blood chloride increased, blood glucose increased, blood potassium increased, body temperature decreased, cold sweat, confusional state. Memantine dosage: unknown. During the same period patient was treated with NORVASC, OSTEOBIFLEX, PRINIVIL, ASPIRIN, LIDODERM, ARICEPT. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #5016971-9
Memantine side effect was reported by a Physician from UNITED STATES on May 19, 2006. Female patient, 87 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: aortic aneurysm , arteriosclerosis, back pain , base excess decreased, blood albumin decreased, blood bicarbonate decreased, blood chloride increased, blood creatinine increased, blood glucose increased. Memantine dosage: unknown. During the same period patient was treated with NORVASC, OSTEOBIFAX, PRINIVIL, VITAMIN, ASPIRIN, LIDODERM PATCH, KADIAN. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5135621-4
Memantine side effect was reported by a Physician from UNITED STATES on Oct 16, 2006. Female patient, 86 years of age, weighting 130.0 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood calcium decreased, blood chloride increased, blood glucose increased, blood potassium decreased, blood sodium increased, blood urea increased, diarrhoea haemorrhagic, diverticulitis. Memantine dosage: 28 MG QD PO. During the same period patient was treated with IMODIUM. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5025456-5
Memantine side effect was reported by a Physician from UNITED STATES on June 06, 2006. Female patient, 86 years of age, weighting 130.0 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood calcium decreased, blood potassium decreased, blood sodium increased, blood urea increased, diarrhoea haemorrhagic, diverticulitis intestinal haemorrhagic, leukocytosis, lymphocyte count increased. Memantine dosage: 28 MG QD PO. During the same period patient was treated with IMODIUM, FLAGYL, PROTONIX, CIPROFLOXACIN. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #4602710-X
Memantine side effect was reported by a Physician from on Feb 28, 2005. Male patient, 85 years of age, weighting 153.6 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood albumin increased, blood chloride increased, blood glucose increased, blood phosphorus decreased, blood potassium increased, bundle branch block left, bundle branch block right, dehydration. Memantine dosage: 20 MG QD PO. During the same period patient was treated with VITAMIN B6, VITAMIN B, VITAMIN C, VITAMIN E, ASPIRIN. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5575721-8
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on Dec 11, 2007. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood cholinesterase decreased, blood creatinine increased, blood glucose increased, blood urea increased, c-reactive protein increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with DONEPEZIL, PROPIVERINE, ANTIBIOTIC, MAGNESIUM OXIDE, TRIMEBUTINE, GLYBURIDE. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #5692109-X
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Mar 18, 2008. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood cholinesterase decreased, blood creatinine increased, blood glucose increased, blood urea increased, cholecystitis. Memantine dosage: 20 MG QD PO. During the same period patient was treated with DONEPEZIL, PROPIVERINE, ANTIBIOTIC, MAGNESIUM OXIDE, TRIMEBUTINE, GLYBURIDE. Patient was hospitalized. Patient died on 01/19/2008.

Memantine Side Effects Report #5015841-X
Memantine side effect was reported by a Health Professional from SWITZERLAND on May 12, 2006. Male patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: antiphospholipid antibodies positive, blood albumin decreased, hepatocellular damage, prothrombin time prolonged. Memantine dosage: 20 MG QD PO. During the same period patient was treated with ZOLOFT, LASIX, NEURONTIN, NEURODOL, VITARUBIN, KONAKION, LAXOBERON. Patient was hospitalized. Patient died on 02/01/2006.

Memantine Side Effects Report #5989156-7
Memantine side effect was reported by a Health Professional from GERMANY on Nov 28, 2008. Male patient, 83 years of age, weighting 121.3 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: ascites, blood albumin decreased, blood creatinine increased, blood pressure increased, blood sodium increased, body temperature decreased, disseminated intravascular coagulation, heart rate increased, laboratory test abnormal. Memantine dosage: 20 MG (20 MG, 1 IN 1 D), ORAL. During the same period patient was treated with FERROUS CITRATE, REBAMIPIDE. Patient was hospitalized. Patient died on 02/12/2006.

Memantine Side Effects Report #4980283-X
Memantine side effect was reported by a Health Professional from JAPAN on Apr 08, 2006. Male patient, 83 years of age, weighting 121.3 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: antithrombin iii decreased, ascites, blood albumin decreased, blood pressure increased, blood pressure systolic increased, body temperature decreased, c-reactive protein increased, creatine phosphokinase decreased, diarrhoea. Memantine dosage: unknown. During the same period patient was treated with FERROUS CITRATE, REBAMIPIDE. Patient was hospitalized. Patient died on 02/12/2006.

Memantine Side Effects Report #4988327-6
Memantine side effect was reported by a Health Professional from JAPAN on Apr 11, 2006. Male patient, 83 years of age, weighting 121.3 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: ascites, blood albumin decreased, blood chloride increased, blood cholesterol decreased, blood creatinine increased, blood glucose increased, blood pressure increased, blood sodium increased, body temperature decreased. Memantine dosage: unknown. During the same period patient was treated with FERROUS CITRATE, REBAMIPIDE. Patient was hospitalized. Patient died on 02/12/2006.


Memantine Side Effects Report #6016915-7
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Dec 10, 2008. Female patient, 81 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: anaemia, blood albumin decreased, blood calcium decreased, blood potassium decreased, hypophagia, malnutrition, urinary tract infection . Memantine dosage: 20 MG (20 MG, 1 IN 1 D), ORAL. During the same period patient was treated with SENNOSIDE, SULFADIAZINE SILVER, PICOSULPHATE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #4963734-6
Memantine side effect was reported by a Health Professional from JAPAN on Oct 03, 2005. Male patient, 74 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ammonia increased, ascites, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatine phosphokinase increased, blood creatinine increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with SULPIRIDE, TOCOPHEROL NICOTINATE, BROTIZOLAM, DONEPEZIL HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #4984588-8
Memantine side effect was reported by a Health Professional from JAPAN on Apr 12, 2006. Male patient, 74 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abdominal pain , alanine aminotransferase increased, ammonia increased, ascites, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood calcium increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with SULPIRIDE, TOCOPHEROL NICOTINATE, BROTIZOLAM, DONEPEZIL HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5036482-4
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on June 12, 2006. Male patient, 74 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, bile duct stone, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatine phosphokinase increased, blood creatinine increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with SULPIRIDE, TOCOPHEROL NICOTINATE, BROTIZOLAM, DONEPEZIL HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #6081483-0
Memantine side effect was reported by a Health Professional from GERMANY on Feb 10, 2009. Male patient, 72 years of age, weighting 132.3 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood albumin decreased, blood glucose increased, blood uric acid increased, deep vein thrombosis , fibrin degradation products increased, gamma-glutamyltransferase increased, haemorrhage, platelet count decreased. Memantine dosage: 20 MG (20 MG, 1 IN 1 D), ORAL. During the same period patient was treated with DIMETHICONE, MOMETASONE FUROATE, DEPRODONE PROPIONATE, DEXAMETHASONE DRY DISTILLATION TAR OF DEFATTING SOYBEAN, INDOMETHACIN, SENNOSIDE, BIFIDOBACTERIUM. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #6122223-6
Memantine side effect was reported by a Health Professional from GERMANY on Mar 04, 2009. Male patient, 72 years of age, weighting 132.3 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood albumin decreased, blood creatine increased, blood glucose increased, blood uric acid increased, deep vein thrombosis , epilepsy , gamma-glutamyltransferase increased, international normalised ratio decreased. Memantine dosage: 20 MG (20 MG,1 IN 1 D),ORAL. During the same period patient was treated with DIMETHICONE, MOMETASONE FUROATE, DEPRODONE PROPIONATE, DEXAMETHASONE DRY DISTILLATION TAR OF DEFATTING SOYBEAN, INDOMETHACIN, SENNOSIDE, BIFIDOBACTERIUM. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5786691-1
Memantine side effect was reported by a Consumer or non-health professional from FRANCE on June 11, 2008. Male patient, 87 years of age, weighting 121.3 lb, was diagnosed with dementia  and was treated with Memantine. After drug was administered, patient experienced the following side effects: bedridden, blood albumin decreased, gait disturbance, malnutrition, pulmonary embolism . Memantine dosage: 20 MG QD PO. During the same period patient was treated with STABLON, EQUANIL, BRICANYL, PULMICORT, IMOVANE. Patient died on 03/24/2008.

Memantine Side Effects Report #5016935-5
Memantine side effect was reported by a Physician from UNITED STATES on May 19, 2006. Female patient, 87 years of age, weighting 116.0 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood glucose increased, blood pressure diastolic decreased, body temperature decreased, confusional state, drooling, haemoglobin decreased, hypotension, lethargy. Memantine dosage: unknown. During the same period patient was treated with NORVASC, OSTEOBIFLEX, PRINIVIL, ASPIRIN, LIDODERM, ARICEPT. Patient was hospitalized. Patient recovered.